News Daily News CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease L.A. McKeown June 29, 2016
News Daily News CABG Revela una Ventaja de Supervivencia sobre la PCI en Pacientes No Diabéticos con Enfermedad Multivaso L.A. McKeown June 29, 2016
News Daily News Según un Meta Análisis en Red el Riesgo de Trombosis del Andamiaje con el BVS Absorb es Mayor que con Otros Stents Michael O'Riordan June 06, 2016
News Daily News Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis Michael O'Riordan June 06, 2016
News Daily News SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease Caitlin E. Cox May 26, 2016
News Daily News La Escala del SYNTAX II Incorporada a las Modernas PCI se Traduce en Beneficios para Pacientes con Enfermedad de 3 Vasos Caitlin E. Cox May 26, 2016
News Conference News EuroPCR 2016 Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events Shelley Wood May 18, 2016
News Conference News EuroPCR 2016 Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining Michael O'Riordan May 17, 2016
News Daily News Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis Michael O'Riordan April 25, 2016
News Daily News Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes Michael O'Riordan April 25, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2016 Shelley Wood March 30, 2016
News Daily News AVB Absorb: Seguridad, Eficacia y Trombosis del Stent a Estudio en 2 Nuevos Análisis Michael O'Riordan March 30, 2016
News Daily News Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses Michael O'Riordan March 30, 2016
Presentation Outcomes with Bioresorbable Vascular Scaffolds versus Everolimus-Eluting Stent Presenter: Sripal Bangalore March 29, 2016
News Industry News Micell Technologies Completes Enrollment in OCT Study Designed to Evaluate Superior Performance of MiStent SES Compared to Xience March 22, 2016
News Daily News Un Panel de la FDA Avala por Mayoría Aplastante el Stent Bioabsorbible Absorb Michael O'Riordan March 16, 2016